← Back to patent-cliff list
CAS 10203-08-4
3,5-Dichlorobenzaldehyde3,5-dichlorobenzaldehyde
Codes：(Ia)409139-7-a、LIFI-011、(II)409139-8-a
Application context (from source-drug indications)
转甲状腺素运载蛋白淀粉样变性氯苯唑酸心脏病氯苯唑酸干眼症利非司特干眼综合征利非司特移植物抗宿主病利非司特糖尿病黄斑水肿利非司特干燥性角结膜炎利非司特变应性结膜炎利非司特淀粉样多神经病氯苯唑酸葡甲胺转甲状腺素运载蛋白淀粉样变性氯苯唑酸葡甲胺淀粉样变氯苯唑酸葡甲胺心肌疾病氯苯唑酸葡甲胺淀粉体轻链淀粉样变性氯苯唑酸葡甲胺家族性淀粉样神经病氯苯唑酸葡甲胺
Source drugs (routes using this intermediate)
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,5-Dichlorobenzaldehyde→3,5-Dichlorobenzoic acid→2-Amino-5-methylphenol→1-Amino-2-hydroxy-4-ethylbenzene→2-Amino-5-butylphenol→(4-Carboxy-2-hydroxyphenyl)amine→2-(3,5-Dichlorophenyl)-6-methyl-1,3-benzoxazole→2-(3,5-Dichlorophenyl)-6-ethyl-1,3-benzoxazole→6-Butyl-2-(3,5-dichlorophenyl)-1,3-benzoxazole→2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid→4-([(1E)-(3,5-Dichlorophenyl)methylene]amino)-3-hydroxybenzoic acid
(S)-2-amino-3-(3-bromophenyl)propanoic acid→(S)-3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid→(S)-2-((tert-butoxycarbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid→(S)-benzyl 2-((tert-butoxycarbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoate→(S)-benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride→5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid→(S)-benzyl 2-(5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate→(S)-benzyl 2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride→benzofuran-6-carboxylic acid→(S)-benzyl 2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate→3,5-dichlorobenzaldehyde→2-chloroethan-1-amine hydrochloride→2-chloro-N-(3,5-dichlorobenzyl)ethanamine→5,7-dichloro-1,2,3,4-tetrahydroisoquinoline→5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline→6-hydroxybenzofuran-3(2H)-one→6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one→benzofuran-6-ol→benzofuran-6-yl trifluoromethanesulfonate→methyl benzofuran-6-carboxylate
2-Hydroxy-4-methoxycarbonylaniline→Butyl 4-amino-3-hydroxybenzoate→tert-Butyl 4-amino-3-hydroxybenzoate→Phenyl 4-amino-3-hydroxybenzoate→3,5-Dichlorobenzaldehyde→2-(3,5-Dichlorophenyl)benzoxazole-6-carboxylic acid methyl ester→Butyl 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate→tert-Butyl 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate→Phenyl 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | benzofuran-6-carboxylic acid Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
| Unibest Taizhou GMP-like Site | 2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
| Qualified Partner — East China API Works | 5,7-Dichloro-1,2,3,4-Tetrahydroisoquinoline-6-Carboxylic Acid Hydrochloride Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
| Unibest Nantong cGMP Site | methyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.